Table 1.
Clinical and laboratory characteristics of subjects with and without ELC
| ELC (−) (n = 75) | ELC (+) (n = 75) | p value | |
|---|---|---|---|
| Age, years | 67±12 | 65±12 | 0.32 |
| Male gender, n | 30 (40) | 38 (50) | 0.15 |
| Diabetes, n | 11 (15) | 22 (29) | 0.02 |
| Smoking, n | 5 (7) | 14 (19) | 0.002 |
| Dyslipidemia | 22 (29) | 15 (20) | 0.17 |
| BMI | 26±5 | 28±6 | 0.004 |
| LDL, mg/dl | 139±37 | 137±38 | 0.18 |
| HDL, mg/dl | 47±12 | 43±13 | 0.25 |
| Triglyceride, mg/dl | 148±68 | 149±69 | 0.79 |
| Cholesterol, mg/dl | 208±44 | 205±51 | 0.33 |
| Systolic blood pressure, mm Hg | 144±23 | 142±21 | 0.61 |
| Diastolic blood pressure, mm Hg | 89±9 | 91±11 | 0.12 |
| Heart rate, beats/min | 76±18 | 72±12 | 0.34 |
| CAVI | 8.6±1.6 | 9.8±2.1 | <0.001 |
| Cardiovascular medication | |||
| ACE inhibitors or ARB, n | 55 (73) | 47 (63) | 0.16 |
| Calcium channel blockers, n | 32 (43) | 29 (39) | 0.42 |
| β-Blockers, n | 18 (24) | 15 (20) | 0.12 |
| Cholesterol-lowering drugs, n | 16 (21) | 13 (17) | 0.51 |
| Aspirin, n | 32 (43) | 23 (31) | 0.21 |
Values in parentheses are percentages. ACE = Angiotensin-converting enzyme; ARB = angiotensin receptor blocker; HDL = high density cholesterol; LDL = low density cholesterol.